 Clinical trials show that olaparib can delay the moment when the disease gets dangerously out of control .
The drug already works for women with BRCA gene mutations , the defect that led to actress Angelina Jolie having her ovaries removed .
New drug is one of the first of a new class of drugs called PARP inhibitors .